All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Tirzepatide and Fertility

Tirzepatide should be stopped before trying to conceive, but the weight loss it provides may improve fertility. Learn about washout periods, PCOS,...

By Dr. Michael Torres, MD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Michael Torres, MD · Reviewed by Dr. David Kim, MD, FACE

Tirzepatide and Fertility custom 2026 header image for GLP-1 Weight Loss
Custom header image for Tirzepatide and Fertility, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Tirzepatide and Fertility

Tirzepatide should be stopped before trying to conceive, but the weight loss it provides may improve fertility. Learn about washout periods, PCOS,...

Short answer

Tirzepatide should be stopped before trying to conceive, but the weight loss it provides may improve fertility. Learn about washout periods, PCOS,...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, hormone labs and monitoring

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Tirzepatide should be stopped before trying to conceive, but the weight loss it provides may improve fertility. Learn about washout periods, PCOS, contraception, and pregnancy planning.

Tirzepatide should be discontinued before trying to conceive, with manufacturers recommending a washout period of at least one month prior to planned pregnancy. But the weight loss tirzepatide provides may actually boost fertility for patients with obesity-related reproductive challenges, including those with PCOS. The relationship between tirzepatide and fertility requires careful planning with your provider.

As tirzepatide prescriptions have surged for both diabetes and weight management, questions about its effects on reproductive health have become increasingly common. Women of childbearing age make up a significant share of patients using this medication, making fertility considerations important to discuss early in treatment.

Why Tirzepatide Must Be Stopped Before Pregnancy

Tirzepatide has a half-life of approximately five days, meaning it takes several weeks to fully clear from your body after the last injection. The prescribing information for both Mounjaro and Zepbound recommends stopping tirzepatide at least one month before a planned pregnancy.

Animal studies at doses exceeding human therapeutic levels showed evidence of adverse developmental effects, including skeletal abnormalities and reduced fetal growth. While human pregnancy data is extremely limited, the precautionary recommendation is to ensure the drug is fully cleared before conception.

How Weight Loss From Tirzepatide Can Improve Fertility

Obesity is a well-established barrier to fertility in both women and men. Excess body fat disrupts hormone production, ovulation patterns, and sperm quality. Even a 5% to 10% reduction in body weight can meaningfully improve reproductive outcomes. For a complete cost breakdown, see our cheapest tirzepatide options.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Tirzepatide and Fertility

For women, weight loss on tirzepatide can:

  • Restore regular ovulatory cycles, especially in patients with PCOS
  • Improve responsiveness to fertility treatments like IVF and IUI
  • Reduce levels of excess estrogen produced by fat tissue
  • Lower the risk of pregnancy complications such as gestational diabetes

For men, weight reduction can raise testosterone levels and improve sperm concentration, motility, and morphology. Some fertility specialists now recommend a structured weight loss phase with medications like tirzepatide before beginning fertility treatment, followed by a proper washout period.

Tirzepatide, PCOS, and Unexpected Ovulation

Polycystic ovary syndrome affects roughly 8% to 13% of women of reproductive age. Many patients with PCOS experience irregular or absent ovulation, which is a primary cause of PCOS-related infertility. Because tirzepatide improves insulin sensitivity and promotes weight loss, it may help restore ovulation in women who had previously stopped ovulating regularly.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

This return of ovulation can catch patients off guard. Some women who believed they were unable to conceive have become pregnant unexpectedly while on tirzepatide or similar GLP-1 medications. If you don't want to become pregnant, use reliable contraception throughout your treatment. tirzepatide and PCOS

Contraception While on Tirzepatide

Tirzepatide slows gastric emptying, which raises a theoretical concern about reduced absorption of oral contraceptive pills. The prescribing information notes this possibility and recommends that patients using oral hormonal contraceptives either switch to a non-oral method or add a backup method (such as condoms) for four weeks after starting tirzepatide and for four weeks after each dose increase.

Non-oral methods such as IUDs, implants, patches, and injections aren't affected by gastric emptying changes and may be more reliable options during tirzepatide treatment.

Frequently Asked Questions

How long before trying to conceive should I stop tirzepatide?

The manufacturer recommends stopping tirzepatide at least one month before attempting pregnancy. Given its approximately five-day half-life, the drug should be substantially cleared within three to four weeks of your last injection. Your provider may recommend a longer washout depending on your individual circumstances.

Can tirzepatide cause permanent infertility?

There's no evidence that tirzepatide causes permanent infertility in humans. The recommendation to stop before pregnancy is a precaution based on animal data at high doses. For many patients, the weight loss from tirzepatide may actually improve fertility compared to their pre-treatment baseline.

What should I do if I get pregnant while taking tirzepatide?

Stop taking tirzepatide immediately and contact your healthcare provider. While the risk from brief early exposure hasn't been fully characterized in humans, prompt discontinuation is the standard recommendation. Your provider can help guide next steps and monitoring.

Does tirzepatide affect birth control pills?

Tirzepatide may reduce the absorption of oral contraceptive pills due to its effect on gastric emptying. The prescribing information recommends using a backup contraceptive method for four weeks after starting tirzepatide and four weeks after each dose escalation. Non-oral contraceptive methods aren't affected. GLP-1 drug interactions

Can tirzepatide help women with PCOS get pregnant?

Indirectly, yes. Weight loss and improved insulin sensitivity from tirzepatide can help restore regular ovulation in women with PCOS. Some reproductive specialists recommend a weight loss phase with tirzepatide before fertility treatment, followed by a washout period before conception attempts begin.

This content is for informational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider regarding fertility and medication decisions.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Mounjaro evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Zepbound evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Tirzepatide and Fertility, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialTirzepatide evidence2022

Tirzepatide Once Weekly for the Treatment of Obesity

Primary SURMOUNT-1 trial source for tirzepatide weight-loss ranges and tolerability.

PubMed

Randomized trialTirzepatide evidence2024

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction

Used for continuation, stopping, and maintenance questions after initial weight loss.

PubMed

Randomized trialTirzepatide evidence2025

Tirzepatide for Obesity Treatment and Diabetes Prevention

Supports newer discussion of obesity treatment and diabetes-prevention outcomes.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2019

GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis

Used for PCOS pages comparing metabolic and weight-management approaches.

PubMed

Systematic reviewPCOS and GLP-1 evidence2024

The efficacy and safety of GLP-1 agonists in PCOS women living with obesity

Supports PCOS, obesity, and hormonal-regulation context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2026

GLP-1 receptor agonist treatment in women with polycystic ovary syndrome

Current review source for pages discussing GLP-1 treatment in PCOS.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Tirzepatide and Fertility research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Tirzepatide should be stopped before trying to conceive, but the weight loss it provides may improve fertility. Learn about washout periods, PCOS, contraception, and pregnancy planning. Use "Tirzepatide and Fertility" to make the conversation more specific before you choose a provider, product, or next step. The page leans into patient education and clinical context and the details behind tirzepatide. Because this article has 5 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. The safest takeaway is a better checklist for clinician review, not a do-it-yourself medical decision.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Tirzepatide and Fertility

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, testosterone, cash-pay pricing, safety signals so the article stays close to the question behind "Tirzepatide and Fertility".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Tirzepatide and Fertility from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Tirzepatide and Fertility custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Tirzepatide and Fertility, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Tirzepatide and Fertility, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Michael Torres, MD

Endocrinologist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.